Cognito Therapeutics announced the appointment of Christian Howell as the Chief Executive Officer, succeeding Brent Vaughan. Mr. Howell brings extensive commercialization expertise to the role, strategically positioning the company for the next phase of growth, with a focus on making therapy accessible to millions of patients suffering from Alzheimer’s disease.
Who to call at Cognito Therapeutics, and when
A new leader at Cognito Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Cognito Therapeutics raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Cognito Therapeutics, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Cognito Therapeutics
Location
55 CAMBRIDGE PKWY
Cambridge, Massachusetts, United States
About
Cognito Therapeutics is a pioneer in non-invasive neuromodulation to treat neurodegenerative diseases and improve human cognitive performance. The company has completed multiple clinical studies demonstrating its investigational therapeutic has the potential to safely slow or stop cognitive decline and loss of brain volume in Alzheimer’s disease.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cognito Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
CambridgeManufacturingHealthcareHealth Care